BioAge Labs, Inc. (BIOA)
9.79
-0.32
(-3.17%)
USD |
NASDAQ |
Aug 26, 09:42
BioAge Labs Debt to Equity Ratio : 0.0076 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0076 |
| March 31, 2026 | 0.0106 |
| December 31, 2025 | 0.0204 |
| September 30, 2025 | 0.0257 |
| June 30, 2025 | 0.0297 |
| March 31, 2025 | 0.0329 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0269 |
| September 30, 2024 | 0.0326 |
| June 30, 2024 | 0.0804 |
| March 31, 2024 | 0.0839 |
| December 31, 2023 | -0.8622 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Oramed Pharmaceuticals, Inc. | 0.0023 |
| Liquidia Corp. | 0.9374 |
| Neumora Therapeutics, Inc. | 1.196 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 396.93M |
| Total Liabilities (Quarterly) | 22.02M |
| Shareholders Equity (Quarterly) | 374.91M |
| Current Ratio | 17.19 |
| Net Debt Paydown Yield | 0.13% |